NCT04059900View on ClinicalTrials.gov

Study in Patients Suffering From Heartburn and Backward Flow of Stomach Liquid Into the Esophagus

PHASE2CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

June 18, 2009

Primary Completion Date

May 3, 2013

Study Completion Date

May 3, 2013

Conditions
Functional Gastrointestinal Disorders
Interventions
DRUG

STW5 (Iberogast®, BAY98-7411)

The medication was applied daily per os (orally, p.o.) from day 0 to day 28. The dosage was 20 drops three times daily before the meals.

DRUG

Placebo

The medication was applied daily p.o. from day 0 to day 28. The dosage was 20 drops three times daily before the meals

Trial Locations (1)

Unknown

Many locations, Multiple Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY